nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrazepam—ABCB1—Methylprednisolone—ankylosing spondylitis	0.114	0.148	CbGbCtD
Nitrazepam—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0855	0.111	CbGbCtD
Nitrazepam—ABCB1—Betamethasone—ankylosing spondylitis	0.0744	0.0964	CbGbCtD
Nitrazepam—ABCB1—Prednisolone—ankylosing spondylitis	0.0734	0.0951	CbGbCtD
Nitrazepam—ABCB1—Prednisone—ankylosing spondylitis	0.0693	0.0898	CbGbCtD
Nitrazepam—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0685	0.0888	CbGbCtD
Nitrazepam—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0519	0.0673	CbGbCtD
Nitrazepam—CYP3A4—Betamethasone—ankylosing spondylitis	0.0446	0.0578	CbGbCtD
Nitrazepam—CYP3A4—Prednisolone—ankylosing spondylitis	0.044	0.057	CbGbCtD
Nitrazepam—ABCB1—Dexamethasone—ankylosing spondylitis	0.0433	0.0561	CbGbCtD
Nitrazepam—CYP3A4—Prednisone—ankylosing spondylitis	0.0415	0.0538	CbGbCtD
Nitrazepam—ABCB1—Methotrexate—ankylosing spondylitis	0.0348	0.0451	CbGbCtD
Nitrazepam—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0259	0.0336	CbGbCtD
Nitrazepam—Sickness—Prednisolone—ankylosing spondylitis	0.0076	0.0432	CcSEcCtD
Nitrazepam—Memory loss—Prednisone—ankylosing spondylitis	0.00522	0.0296	CcSEcCtD
Nitrazepam—Abnormal behaviour—Methylprednisolone—ankylosing spondylitis	0.0052	0.0295	CcSEcCtD
Nitrazepam—Withdrawal symptom—Methylprednisolone—ankylosing spondylitis	0.00472	0.0268	CcSEcCtD
Nitrazepam—Withdrawal symptom—Dexamethasone—ankylosing spondylitis	0.00429	0.0244	CcSEcCtD
Nitrazepam—Withdrawal symptom—Betamethasone—ankylosing spondylitis	0.00429	0.0244	CcSEcCtD
Nitrazepam—Drug withdrawal syndrome—Methylprednisolone—ankylosing spondylitis	0.00395	0.0224	CcSEcCtD
Nitrazepam—Withdrawal symptom—Prednisone—ankylosing spondylitis	0.00374	0.0212	CcSEcCtD
Nitrazepam—Drug withdrawal syndrome—Dexamethasone—ankylosing spondylitis	0.00359	0.0204	CcSEcCtD
Nitrazepam—Drug withdrawal syndrome—Betamethasone—ankylosing spondylitis	0.00359	0.0204	CcSEcCtD
Nitrazepam—Drug withdrawal syndrome—Prednisone—ankylosing spondylitis	0.00313	0.0178	CcSEcCtD
Nitrazepam—GABRQ—Orphan transporters—ANO6—ankylosing spondylitis	0.00261	0.0497	CbGpPWpGaD
Nitrazepam—GABRG3—Orphan transporters—ANO6—ankylosing spondylitis	0.00215	0.0409	CbGpPWpGaD
Nitrazepam—GABRB1—Orphan transporters—ANO6—ankylosing spondylitis	0.00211	0.0403	CbGpPWpGaD
Nitrazepam—GABRA6—Orphan transporters—ANO6—ankylosing spondylitis	0.002	0.0381	CbGpPWpGaD
Nitrazepam—GABRA4—Orphan transporters—ANO6—ankylosing spondylitis	0.00197	0.0377	CbGpPWpGaD
Nitrazepam—Memory impairment—Prednisone—ankylosing spondylitis	0.00195	0.0111	CcSEcCtD
Nitrazepam—GABRR1—Ion channel transport—ANO6—ankylosing spondylitis	0.00192	0.0365	CbGpPWpGaD
Nitrazepam—GABRQ—Ion channel transport—ANO6—ankylosing spondylitis	0.00183	0.0349	CbGpPWpGaD
Nitrazepam—GABRR2—Ion channel transport—ANO6—ankylosing spondylitis	0.00183	0.0349	CbGpPWpGaD
Nitrazepam—GABRB2—Orphan transporters—ANO6—ankylosing spondylitis	0.00181	0.0344	CbGpPWpGaD
Nitrazepam—GABRA5—Orphan transporters—ANO6—ankylosing spondylitis	0.00175	0.0335	CbGpPWpGaD
Nitrazepam—GABRA3—Orphan transporters—ANO6—ankylosing spondylitis	0.00172	0.0329	CbGpPWpGaD
Nitrazepam—GABRA2—Orphan transporters—ANO6—ankylosing spondylitis	0.00169	0.0323	CbGpPWpGaD
Nitrazepam—GABRB3—Orphan transporters—ANO6—ankylosing spondylitis	0.00168	0.0321	CbGpPWpGaD
Nitrazepam—GABRG2—Orphan transporters—ANO6—ankylosing spondylitis	0.00165	0.0315	CbGpPWpGaD
Nitrazepam—GABRG3—Ion channel transport—ANO6—ankylosing spondylitis	0.00151	0.0287	CbGpPWpGaD
Nitrazepam—Amnesia—Methylprednisolone—ankylosing spondylitis	0.0015	0.0085	CcSEcCtD
Nitrazepam—GABRB1—Ion channel transport—ANO6—ankylosing spondylitis	0.00148	0.0283	CbGpPWpGaD
Nitrazepam—GABRA1—Orphan transporters—ANO6—ankylosing spondylitis	0.00144	0.0275	CbGpPWpGaD
Nitrazepam—GABRA6—Ion channel transport—ANO6—ankylosing spondylitis	0.0014	0.0268	CbGpPWpGaD
Nitrazepam—GABRA4—Ion channel transport—ANO6—ankylosing spondylitis	0.00139	0.0264	CbGpPWpGaD
Nitrazepam—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00137	0.0078	CcSEcCtD
Nitrazepam—Dysarthria—Methotrexate—ankylosing spondylitis	0.00135	0.00769	CcSEcCtD
Nitrazepam—Muscular weakness—Prednisolone—ankylosing spondylitis	0.00135	0.00767	CcSEcCtD
Nitrazepam—Irritability—Methylprednisolone—ankylosing spondylitis	0.00134	0.00762	CcSEcCtD
Nitrazepam—Hyperkinesia—Prednisone—ankylosing spondylitis	0.00134	0.0076	CcSEcCtD
Nitrazepam—Lethargy—Dexamethasone—ankylosing spondylitis	0.0013	0.00741	CcSEcCtD
Nitrazepam—Lethargy—Betamethasone—ankylosing spondylitis	0.0013	0.00741	CcSEcCtD
Nitrazepam—GABRB2—Ion channel transport—ANO6—ankylosing spondylitis	0.00127	0.0242	CbGpPWpGaD
Nitrazepam—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00125	0.00709	CcSEcCtD
Nitrazepam—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00125	0.00709	CcSEcCtD
Nitrazepam—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00124	0.00706	CcSEcCtD
Nitrazepam—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00124	0.00704	CcSEcCtD
Nitrazepam—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.00124	0.00703	CcSEcCtD
Nitrazepam—GABRA5—Ion channel transport—ANO6—ankylosing spondylitis	0.00123	0.0235	CbGpPWpGaD
Nitrazepam—Irritability—Dexamethasone—ankylosing spondylitis	0.00122	0.00693	CcSEcCtD
Nitrazepam—Irritability—Betamethasone—ankylosing spondylitis	0.00122	0.00693	CcSEcCtD
Nitrazepam—GABRA3—Ion channel transport—ANO6—ankylosing spondylitis	0.00121	0.0231	CbGpPWpGaD
Nitrazepam—GABRA2—Ion channel transport—ANO6—ankylosing spondylitis	0.00119	0.0227	CbGpPWpGaD
Nitrazepam—Amnesia—Prednisone—ankylosing spondylitis	0.00118	0.00673	CcSEcCtD
Nitrazepam—GABRB3—Ion channel transport—ANO6—ankylosing spondylitis	0.00118	0.0225	CbGpPWpGaD
Nitrazepam—GABRG2—Ion channel transport—ANO6—ankylosing spondylitis	0.00116	0.0221	CbGpPWpGaD
Nitrazepam—Lethargy—Prednisone—ankylosing spondylitis	0.00114	0.00645	CcSEcCtD
Nitrazepam—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00113	0.0064	CcSEcCtD
Nitrazepam—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00113	0.0064	CcSEcCtD
Nitrazepam—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00109	0.00617	CcSEcCtD
Nitrazepam—Irritability—Prednisone—ankylosing spondylitis	0.00106	0.00603	CcSEcCtD
Nitrazepam—Sweating—Methylprednisolone—ankylosing spondylitis	0.00104	0.0059	CcSEcCtD
Nitrazepam—GABRA1—Ion channel transport—ANO6—ankylosing spondylitis	0.00101	0.0193	CbGpPWpGaD
Nitrazepam—Muscular weakness—Prednisone—ankylosing spondylitis	0.000982	0.00558	CcSEcCtD
Nitrazepam—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000967	0.00549	CcSEcCtD
Nitrazepam—Lethargy—Methotrexate—ankylosing spondylitis	0.000949	0.00539	CcSEcCtD
Nitrazepam—Irritability—Methotrexate—ankylosing spondylitis	0.000888	0.00504	CcSEcCtD
Nitrazepam—Hallucination—Betamethasone—ankylosing spondylitis	0.00088	0.005	CcSEcCtD
Nitrazepam—Hallucination—Dexamethasone—ankylosing spondylitis	0.00088	0.005	CcSEcCtD
Nitrazepam—Ataxia—Methotrexate—ankylosing spondylitis	0.000875	0.00497	CcSEcCtD
Nitrazepam—Vision blurred—Prednisolone—ankylosing spondylitis	0.000869	0.00494	CcSEcCtD
Nitrazepam—Malaise—Prednisolone—ankylosing spondylitis	0.000832	0.00472	CcSEcCtD
Nitrazepam—Vertigo—Prednisolone—ankylosing spondylitis	0.000829	0.00471	CcSEcCtD
Nitrazepam—Syncope—Prednisolone—ankylosing spondylitis	0.000827	0.0047	CcSEcCtD
Nitrazepam—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000811	0.0046	CcSEcCtD
Nitrazepam—Convulsion—Prednisolone—ankylosing spondylitis	0.000799	0.00454	CcSEcCtD
Nitrazepam—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000771	0.00438	CcSEcCtD
Nitrazepam—Hallucination—Prednisone—ankylosing spondylitis	0.000766	0.00435	CcSEcCtD
Nitrazepam—Malaise—Triamcinolone—ankylosing spondylitis	0.000765	0.00434	CcSEcCtD
Nitrazepam—Malaise—Methylprednisolone—ankylosing spondylitis	0.000763	0.00433	CcSEcCtD
Nitrazepam—Vertigo—Triamcinolone—ankylosing spondylitis	0.000762	0.00433	CcSEcCtD
Nitrazepam—Syncope—Triamcinolone—ankylosing spondylitis	0.000761	0.00432	CcSEcCtD
Nitrazepam—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00076	0.00432	CcSEcCtD
Nitrazepam—Syncope—Methylprednisolone—ankylosing spondylitis	0.000759	0.00431	CcSEcCtD
Nitrazepam—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000745	0.00423	CcSEcCtD
Nitrazepam—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000744	0.00423	CcSEcCtD
Nitrazepam—Shock—Prednisolone—ankylosing spondylitis	0.000741	0.00421	CcSEcCtD
Nitrazepam—Convulsion—Triamcinolone—ankylosing spondylitis	0.000735	0.00417	CcSEcCtD
Nitrazepam—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000733	0.00416	CcSEcCtD
Nitrazepam—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000728	0.00413	CcSEcCtD
Nitrazepam—Pneumonia—Methotrexate—ankylosing spondylitis	0.000721	0.00409	CcSEcCtD
Nitrazepam—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000718	0.00408	CcSEcCtD
Nitrazepam—Drowsiness—Methotrexate—ankylosing spondylitis	0.000717	0.00407	CcSEcCtD
Nitrazepam—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000696	0.00396	CcSEcCtD
Nitrazepam—Malaise—Dexamethasone—ankylosing spondylitis	0.000694	0.00394	CcSEcCtD
Nitrazepam—Malaise—Betamethasone—ankylosing spondylitis	0.000694	0.00394	CcSEcCtD
Nitrazepam—Vertigo—Dexamethasone—ankylosing spondylitis	0.000691	0.00393	CcSEcCtD
Nitrazepam—Vertigo—Betamethasone—ankylosing spondylitis	0.000691	0.00393	CcSEcCtD
Nitrazepam—Syncope—Betamethasone—ankylosing spondylitis	0.00069	0.00392	CcSEcCtD
Nitrazepam—Syncope—Dexamethasone—ankylosing spondylitis	0.00069	0.00392	CcSEcCtD
Nitrazepam—Infection—Triamcinolone—ankylosing spondylitis	0.000688	0.00391	CcSEcCtD
Nitrazepam—Sweating—Methotrexate—ankylosing spondylitis	0.000687	0.0039	CcSEcCtD
Nitrazepam—Infection—Methylprednisolone—ankylosing spondylitis	0.000686	0.0039	CcSEcCtD
Nitrazepam—Shock—Triamcinolone—ankylosing spondylitis	0.000681	0.00387	CcSEcCtD
Nitrazepam—Shock—Methylprednisolone—ankylosing spondylitis	0.00068	0.00386	CcSEcCtD
Nitrazepam—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000676	0.00384	CcSEcCtD
Nitrazepam—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000676	0.00384	CcSEcCtD
Nitrazepam—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000676	0.00384	CcSEcCtD
Nitrazepam—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000669	0.0038	CcSEcCtD
Nitrazepam—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000669	0.0038	CcSEcCtD
Nitrazepam—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000668	0.00379	CcSEcCtD
Nitrazepam—GABRR1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000667	0.0127	CbGpPWpGaD
Nitrazepam—Convulsion—Dexamethasone—ankylosing spondylitis	0.000667	0.00379	CcSEcCtD
Nitrazepam—Convulsion—Betamethasone—ankylosing spondylitis	0.000667	0.00379	CcSEcCtD
Nitrazepam—Anxiety—Dexamethasone—ankylosing spondylitis	0.000653	0.00371	CcSEcCtD
Nitrazepam—Anxiety—Betamethasone—ankylosing spondylitis	0.000653	0.00371	CcSEcCtD
Nitrazepam—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000645	0.00367	CcSEcCtD
Nitrazepam—GABRQ—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000636	0.0121	CbGpPWpGaD
Nitrazepam—GABRR2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000636	0.0121	CbGpPWpGaD
Nitrazepam—Vision blurred—Prednisone—ankylosing spondylitis	0.000632	0.00359	CcSEcCtD
Nitrazepam—Infection—Betamethasone—ankylosing spondylitis	0.000624	0.00354	CcSEcCtD
Nitrazepam—Infection—Dexamethasone—ankylosing spondylitis	0.000624	0.00354	CcSEcCtD
Nitrazepam—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000622	0.00353	CcSEcCtD
Nitrazepam—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00062	0.00352	CcSEcCtD
Nitrazepam—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00062	0.00352	CcSEcCtD
Nitrazepam—Shock—Dexamethasone—ankylosing spondylitis	0.000618	0.00351	CcSEcCtD
Nitrazepam—Shock—Betamethasone—ankylosing spondylitis	0.000618	0.00351	CcSEcCtD
Nitrazepam—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000617	0.00351	CcSEcCtD
Nitrazepam—Agitation—Prednisone—ankylosing spondylitis	0.000616	0.0035	CcSEcCtD
Nitrazepam—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000609	0.00346	CcSEcCtD
Nitrazepam—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000608	0.00345	CcSEcCtD
Nitrazepam—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000607	0.00345	CcSEcCtD
Nitrazepam—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000607	0.00345	CcSEcCtD
Nitrazepam—Malaise—Prednisone—ankylosing spondylitis	0.000604	0.00343	CcSEcCtD
Nitrazepam—Vertigo—Prednisone—ankylosing spondylitis	0.000602	0.00342	CcSEcCtD
Nitrazepam—Syncope—Prednisone—ankylosing spondylitis	0.000601	0.00341	CcSEcCtD
Nitrazepam—Fatigue—Triamcinolone—ankylosing spondylitis	0.000597	0.00339	CcSEcCtD
Nitrazepam—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000595	0.00338	CcSEcCtD
Nitrazepam—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000589	0.00335	CcSEcCtD
Nitrazepam—Hypotension—Dexamethasone—ankylosing spondylitis	0.000587	0.00333	CcSEcCtD
Nitrazepam—Hypotension—Betamethasone—ankylosing spondylitis	0.000587	0.00333	CcSEcCtD
Nitrazepam—Convulsion—Prednisone—ankylosing spondylitis	0.000581	0.0033	CcSEcCtD
Nitrazepam—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00057	0.00324	CcSEcCtD
Nitrazepam—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000569	0.00323	CcSEcCtD
Nitrazepam—Anxiety—Prednisone—ankylosing spondylitis	0.000569	0.00323	CcSEcCtD
Nitrazepam—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000564	0.0032	CcSEcCtD
Nitrazepam—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000564	0.0032	CcSEcCtD
Nitrazepam—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000555	0.00315	CcSEcCtD
Nitrazepam—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000553	0.00314	CcSEcCtD
Nitrazepam—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000553	0.00314	CcSEcCtD
Nitrazepam—Infection—Prednisone—ankylosing spondylitis	0.000543	0.00309	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000542	0.00308	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000542	0.00308	CcSEcCtD
Nitrazepam—Fatigue—Betamethasone—ankylosing spondylitis	0.000542	0.00308	CcSEcCtD
Nitrazepam—Fatigue—Dexamethasone—ankylosing spondylitis	0.000542	0.00308	CcSEcCtD
Nitrazepam—Shock—Prednisone—ankylosing spondylitis	0.000538	0.00306	CcSEcCtD
Nitrazepam—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000529	0.003	CcSEcCtD
Nitrazepam—Vision blurred—Methotrexate—ankylosing spondylitis	0.000528	0.003	CcSEcCtD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000524	0.00999	CbGpPWpGaD
Nitrazepam—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000518	0.00294	CcSEcCtD
Nitrazepam—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000518	0.00294	CcSEcCtD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000516	0.00984	CbGpPWpGaD
Nitrazepam—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00051	0.0029	CcSEcCtD
Nitrazepam—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000509	0.00289	CcSEcCtD
Nitrazepam—Malaise—Methotrexate—ankylosing spondylitis	0.000505	0.00287	CcSEcCtD
Nitrazepam—Vertigo—Methotrexate—ankylosing spondylitis	0.000503	0.00286	CcSEcCtD
Nitrazepam—Leukopenia—Methotrexate—ankylosing spondylitis	0.000501	0.00285	CcSEcCtD
Nitrazepam—Dizziness—Prednisolone—ankylosing spondylitis	0.000498	0.00283	CcSEcCtD
Nitrazepam—Asthenia—Triamcinolone—ankylosing spondylitis	0.000497	0.00282	CcSEcCtD
Nitrazepam—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000496	0.00281	CcSEcCtD
Nitrazepam—Paraesthesia—Prednisone—ankylosing spondylitis	0.000491	0.00279	CcSEcCtD
Nitrazepam—Pruritus—Triamcinolone—ankylosing spondylitis	0.00049	0.00278	CcSEcCtD
Nitrazepam—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000489	0.00278	CcSEcCtD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000488	0.00931	CbGpPWpGaD
Nitrazepam—Convulsion—Methotrexate—ankylosing spondylitis	0.000485	0.00276	CcSEcCtD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000482	0.0092	CbGpPWpGaD
Nitrazepam—Dyspepsia—Prednisone—ankylosing spondylitis	0.000481	0.00273	CcSEcCtD
Nitrazepam—Rash—Prednisolone—ankylosing spondylitis	0.000475	0.0027	CcSEcCtD
Nitrazepam—Dermatitis—Prednisolone—ankylosing spondylitis	0.000474	0.00269	CcSEcCtD
Nitrazepam—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000473	0.00268	CcSEcCtD
Nitrazepam—Fatigue—Prednisone—ankylosing spondylitis	0.000472	0.00268	CcSEcCtD
Nitrazepam—Headache—Prednisolone—ankylosing spondylitis	0.000472	0.00268	CcSEcCtD
Nitrazepam—Constipation—Prednisone—ankylosing spondylitis	0.000468	0.00266	CcSEcCtD
Nitrazepam—Confusional state—Methotrexate—ankylosing spondylitis	0.000461	0.00262	CcSEcCtD
Nitrazepam—Dizziness—Triamcinolone—ankylosing spondylitis	0.000458	0.0026	CcSEcCtD
Nitrazepam—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000457	0.00259	CcSEcCtD
Nitrazepam—Infection—Methotrexate—ankylosing spondylitis	0.000454	0.00258	CcSEcCtD
Nitrazepam—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000451	0.00256	CcSEcCtD
Nitrazepam—Asthenia—Dexamethasone—ankylosing spondylitis	0.000451	0.00256	CcSEcCtD
Nitrazepam—Asthenia—Betamethasone—ankylosing spondylitis	0.000451	0.00256	CcSEcCtD
Nitrazepam—Nausea—Prednisolone—ankylosing spondylitis	0.000447	0.00254	CcSEcCtD
Nitrazepam—Pruritus—Betamethasone—ankylosing spondylitis	0.000444	0.00252	CcSEcCtD
Nitrazepam—Pruritus—Dexamethasone—ankylosing spondylitis	0.000444	0.00252	CcSEcCtD
Nitrazepam—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000442	0.00251	CcSEcCtD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000441	0.00841	CbGpPWpGaD
Nitrazepam—Vomiting—Triamcinolone—ankylosing spondylitis	0.00044	0.0025	CcSEcCtD
Nitrazepam—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000439	0.00249	CcSEcCtD
Nitrazepam—Rash—Triamcinolone—ankylosing spondylitis	0.000436	0.00248	CcSEcCtD
Nitrazepam—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000436	0.00248	CcSEcCtD
Nitrazepam—Rash—Methylprednisolone—ankylosing spondylitis	0.000435	0.00247	CcSEcCtD
Nitrazepam—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000435	0.00247	CcSEcCtD
Nitrazepam—Headache—Triamcinolone—ankylosing spondylitis	0.000434	0.00246	CcSEcCtD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000434	0.00827	CbGpPWpGaD
Nitrazepam—Headache—Methylprednisolone—ankylosing spondylitis	0.000433	0.00246	CcSEcCtD
Nitrazepam—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00043	0.00244	CcSEcCtD
Nitrazepam—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00043	0.00244	CcSEcCtD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000428	0.00817	CbGpPWpGaD
Nitrazepam—Hypotension—Methotrexate—ankylosing spondylitis	0.000427	0.00243	CcSEcCtD
Nitrazepam—GABRA3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000421	0.00802	CbGpPWpGaD
Nitrazepam—Dizziness—Betamethasone—ankylosing spondylitis	0.000415	0.00236	CcSEcCtD
Nitrazepam—Dizziness—Dexamethasone—ankylosing spondylitis	0.000415	0.00236	CcSEcCtD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000413	0.00788	CbGpPWpGaD
Nitrazepam—Nausea—Triamcinolone—ankylosing spondylitis	0.000411	0.00234	CcSEcCtD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000411	0.00783	CbGpPWpGaD
Nitrazepam—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00041	0.00233	CcSEcCtD
Nitrazepam—Nausea—Methylprednisolone—ankylosing spondylitis	0.00041	0.00233	CcSEcCtD
Nitrazepam—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000408	0.00231	CcSEcCtD
Nitrazepam—Somnolence—Methotrexate—ankylosing spondylitis	0.000406	0.00231	CcSEcCtD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000403	0.00769	CbGpPWpGaD
Nitrazepam—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000403	0.00229	CcSEcCtD
Nitrazepam—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000402	0.00229	CcSEcCtD
Nitrazepam—Vomiting—Betamethasone—ankylosing spondylitis	0.000399	0.00227	CcSEcCtD
Nitrazepam—Vomiting—Dexamethasone—ankylosing spondylitis	0.000399	0.00227	CcSEcCtD
Nitrazepam—Rash—Betamethasone—ankylosing spondylitis	0.000396	0.00225	CcSEcCtD
Nitrazepam—Rash—Dexamethasone—ankylosing spondylitis	0.000396	0.00225	CcSEcCtD
Nitrazepam—Dermatitis—Betamethasone—ankylosing spondylitis	0.000396	0.00225	CcSEcCtD
Nitrazepam—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000396	0.00225	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000395	0.00224	CcSEcCtD
Nitrazepam—Fatigue—Methotrexate—ankylosing spondylitis	0.000394	0.00224	CcSEcCtD
Nitrazepam—Headache—Betamethasone—ankylosing spondylitis	0.000393	0.00224	CcSEcCtD
Nitrazepam—Headache—Dexamethasone—ankylosing spondylitis	0.000393	0.00224	CcSEcCtD
Nitrazepam—Asthenia—Prednisone—ankylosing spondylitis	0.000392	0.00223	CcSEcCtD
Nitrazepam—Pruritus—Prednisone—ankylosing spondylitis	0.000387	0.0022	CcSEcCtD
Nitrazepam—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000377	0.00214	CcSEcCtD
Nitrazepam—Diarrhoea—Prednisone—ankylosing spondylitis	0.000374	0.00213	CcSEcCtD
Nitrazepam—Nausea—Dexamethasone—ankylosing spondylitis	0.000373	0.00212	CcSEcCtD
Nitrazepam—Nausea—Betamethasone—ankylosing spondylitis	0.000373	0.00212	CcSEcCtD
Nitrazepam—Dizziness—Prednisone—ankylosing spondylitis	0.000362	0.00205	CcSEcCtD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000353	0.00672	CbGpPWpGaD
Nitrazepam—Vomiting—Prednisone—ankylosing spondylitis	0.000348	0.00198	CcSEcCtD
Nitrazepam—Rash—Prednisone—ankylosing spondylitis	0.000345	0.00196	CcSEcCtD
Nitrazepam—Dermatitis—Prednisone—ankylosing spondylitis	0.000345	0.00196	CcSEcCtD
Nitrazepam—Headache—Prednisone—ankylosing spondylitis	0.000343	0.00195	CcSEcCtD
Nitrazepam—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000337	0.00191	CcSEcCtD
Nitrazepam—Asthenia—Methotrexate—ankylosing spondylitis	0.000328	0.00186	CcSEcCtD
Nitrazepam—Nausea—Prednisone—ankylosing spondylitis	0.000325	0.00185	CcSEcCtD
Nitrazepam—Pruritus—Methotrexate—ankylosing spondylitis	0.000323	0.00184	CcSEcCtD
Nitrazepam—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000313	0.00178	CcSEcCtD
Nitrazepam—Dizziness—Methotrexate—ankylosing spondylitis	0.000302	0.00172	CcSEcCtD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000299	0.00571	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000298	0.00568	CbGpPWpGaD
Nitrazepam—Vomiting—Methotrexate—ankylosing spondylitis	0.000291	0.00165	CcSEcCtD
Nitrazepam—Rash—Methotrexate—ankylosing spondylitis	0.000288	0.00164	CcSEcCtD
Nitrazepam—Dermatitis—Methotrexate—ankylosing spondylitis	0.000288	0.00164	CcSEcCtD
Nitrazepam—Headache—Methotrexate—ankylosing spondylitis	0.000286	0.00163	CcSEcCtD
Nitrazepam—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000272	0.00519	CbGpPWpGaD
Nitrazepam—Nausea—Methotrexate—ankylosing spondylitis	0.000272	0.00154	CcSEcCtD
Nitrazepam—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000253	0.00483	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000215	0.00411	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000214	0.00408	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000186	0.00355	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.000185	0.00353	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000185	0.00353	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000177	0.00337	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000176	0.00336	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000163	0.00311	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	8.15e-05	0.00155	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	7.04e-05	0.00134	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—TNF—ankylosing spondylitis	7e-05	0.00133	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	4.91e-05	0.000937	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	3.7e-05	0.000705	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	3.48e-05	0.000663	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	2.28e-05	0.000435	CbGpPWpGaD
